IRL 1620, Succinyl‐[Glu9,Ala11,15]‐Endothelin‐1(8‐21), A Highly Specific Agonist of the ETB Receptor
- 1 September 1993
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 11 (3) , 253-270
- https://doi.org/10.1111/j.1527-3466.1993.tb00190.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A novel subtype of endothelin B receptor mediating contraction in swine pulmonary veinLife Sciences, 1993
- Contraction of smooth muscle by activation of endothelin receptors on autonomic neuronsFEBS Letters, 1993
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Non-isopeptide-selective endothelin receptors in human girardi heart cellsLife Sciences, 1992
- Pharmacologic Characterization of an EndothelinA (ETA) Receptor Antagonist in Conscious RatsJournal of Cardiovascular Pharmacology, 1992
- An endothelin B receptor‐selective antagonist: IRL 1038, [Cys11‐Cys15]‐endothelin‐1(11–21)FEBS Letters, 1992
- A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8–21), [125I]IRL 1620Biochemical and Biophysical Research Communications, 1992
- A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptorBiochemical and Biophysical Research Communications, 1992
- Endothelin and structurally related analogs distinguish between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1992
- [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activityBiochemical and Biophysical Research Communications, 1991